MedWatch

Four firms received USD 840m for running rapid Covid-19 tests in Denmark

35 million rapid tests for Covid-19 were taken from December last year to September of this year, bringing in DKK 5.4bn (USD 840m) for the four companies behind the testing capacity. According to one provider, the firms have also run a "very big risk."

Photo: Martin Lehmann

From Dec. 12, 2020, to Sep. 24, 2021,  on behalf of the five Danish regions, four firms have handled rapid tests for Covid-19: Falck, Copenhagen Contractors, Carelink and SOS International. During this period, the firms have brought in a total of DKK 5.4bn (USD 840m), Danish financial daily Børsen reports.

Falck, which was responsible for testing in three regions, has a considerable lead, having earned DKK 2.6bn (USD 400m). Communicatons Director at the firm Lise Kirkegaard reveals that the company expects a total profit of DKK 1bn from its testing activities in 2021.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.

Eli Lilly upgrades earnings per share guidance

On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.

Further reading

Related articles

Trial banner

Latest news

See all jobs